All supplements

Supplement evidence

114 / 575Joint & connective tissue

Bromelain

View my plan

The short answer

Trials examine postoperative swelling and joint symptoms, but dosing and evidence quality vary.

Evidence and scope
Mixed evidence

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
Trials are inconsistent or small, so a reliable clinically important benefit is not established.
Before deciding
Key concern: Anticoagulants, antibiotics, pineapple allergy, ulcers, and surgery require review.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective
Joint symptoms200–800 mg/day standardized by enzyme activity in trials

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityWater-soluble

Water-soluble or readily water-dispersible. This does not mean excess is always harmless.

How it is commonly taken

Use enzyme-activity units; food timing depends on the objective.

Do not combine casually

Anticoagulants, antibiotics, pineapple allergy, ulcers, and surgery require review.

Dose and use source

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

1research papers in this ledger
54unique primary studies represented
unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2023
Mixed or qualifiedPMID 37157782

Efficacy and safety of bromelain

Oral bromelain produced a small pooled pain reduction and may help sinusitis, but did not improve cardiovascular disease outcomes. Topical wound-debridement findings are a different route and cannot support oral supplements; oral adverse effects included gas, nausea, and headache.

Study design and methods
Design
Systematic review of 54 articles; 39 entered meta-analyses
Population
Mixed clinical populations receiving oral or topical bromelain; the abstract did not report a participant total
Intervention
Oral or topical bromelain versus varied controls
Outcome
Pain, sinusitis, cardiovascular outcomes, wound debridement, and adverse events
Open research record
Unscreened discovery appendix—not evidence76 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. Prevention of lymphedema after extended pelvic lymphadenectomy using diosmin, bromelain, melilotus, and hesperidin: results from a prospective randomized study (PRELYNE trial).Montanaro F, Pettenuzzo G, Malandra S et al. · 2026 · Journal of robotic surgery · PMID 42616207Open on PubMed
  2. Investigation of oral bromelain supplementation on the healing of skin flap reconstruction after Mohs micrographic surgery (MMS) for non-melanoma skin cancers (NMSCs).Rahimi-Movaghar E, Ehtemami A, Ghaneiyan M et al. · 2026 · BMC surgery · PMID 42135693Open on PubMed
  3. Efficacy and Safety of Bromelain-Based Enzymatic Debridement for Chronic Wounds: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.Günay UB, Tanin MK, Demiröz A · 2026 · Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · PMID 41700487Open on PubMed
  4. The Correlation Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers: A Post Hoc Analysis of the ChronEx Multicenter Randomized Controlled Trial.Carter MJ, Snyder RJ, Zarbiv KD et al. · 2026 · Advances in wound care · PMID 40796323Open on PubMed
  5. Interventions for reducing bleeding and swelling in eyelid and periocular surgeries: a systematic review of randomized controlled trials.Alamoudi A, Albishry AM, Alnabihi AN et al. · 2025 · Orbit (Amsterdam, Netherlands) · PMID 41264874Open on PubMed
  6. Effects of bromelain supplementation on disease activity and quality of life in patients with ulcerative colitis: a randomized, triple-blind, placebo-controlled study.Delgarm P, Mokhtare M, Ebrahimi Daryani N et al. · 2025 · Scientific reports · PMID 41315628Open on PubMed
  7. Systemic enzyme therapy for postoperative inflammation and wound healing after orthopedic surgery: a randomized, placebo and active controlled clinical study.Suryawanshi A, Patkar H, Aute S et al. · 2025 · Scientific reports · PMID 41038853Open on PubMed
  8. Efficacy and safety of Atusin(®) CAP in the treatment of acute uncomplicated bronchitis in the primary care setting: a multi-center, randomized, double-blind, placebo-controlled study (AABA).Petkova D, Petkov R, Hodzhev V et al. · 2025 · BMC pulmonary medicine · PMID 41034950Open on PubMed
  9. Bromelain-Rich Pineapple Extract for the Treatment of Pediatric Patients With Orchiepididymitis: A Randomized Clinical Pilot Study.Colletti A, Sangiorgio L, Martelli A et al. · 2025 · Molecular nutrition & food research · PMID 40534304Open on PubMed
  10. Oral enzyme combination therapy reduces systemic inflammation, urinary CTXII and pain in knee osteoarthritis: a proof-of-mechanism, randomised, crossover, double-blind, placebo-controlled trial.Henrotin Y, Pap T, Lieten S et al. · 2025 · RMD open · PMID 40803821Open on PubMed
  11. The Effectiveness of Bromelain on Oedema, Subconjunctival Haemorrhage, and Ecchymosis After Rhinoplasty: A Randomised, Double-Blind, Placebo-Controlled Trial.Rahmaty B, Naraghi M, Mesbahi A et al. · 2025 · Aesthetic plastic surgery · PMID 39904804Open on PubMed
  12. COMBINED INTRAVITREAL AFLIBERCEPT AND ANTI-INFLAMMATORY ORAL SUPPLEMENTATION IN THE TREATMENT OF DIABETIC MACULAR EDEMA: Two-Year Randomized Controlled Trial Results.Marolo P, Volti GL, Nicolosi A et al. · 2025 · Retina (Philadelphia, Pa.) · PMID 39977849Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.